Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NSD2 | O96028 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13851151 | 0.83 | HTT (0.64) | HTTLMNAKDM4EMAPTHSD17B10 | |
| SCHEMBL29771838 | 0.83 | HTT (0.64) | HTTLMNAKDM4EMAPTHSD17B10 | |
| SCHEMBL5185496 | 0.81 | HTT (0.61) | HTTLMNAKDM4EMAPTHSD17B10 | |
| Vitamin K3H2 SCHEMBL29525544 | 0.81 | HTT (1.00) | HTTLMNAKDM4EMAPTHSD17B10 | |
| Vitamin K3H2 SCHEMBL297164 | 0.81 | HTT (1.00) | HTTLMNAKDM4EMAPTHSD17B10 | |
| Vitamin K3H2 SCHEMBL2887680 | 0.79 | HTT (0.95) | HTTLMNAKDM4EMAPTHSD17B10 | |
| SCHEMBL353534 | 0.77 | HTT (0.63) | HTTLMNAKDM4EMAPTHSD17B10 | |
| SCHEMBL13933689 | 0.77 | HTT (0.63) | HTTLMNAKDM4EMAPTHSD17B10 | |
| SCHEMBL29344185 | 0.77 | HTT (0.63) | HTTLMNAKDM4EMAPTHSD17B10 | |
| SCHEMBL16622867 | 0.77 | HTT (0.63) | HTTLMNAKDM4EMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0330504-B1 | Photosensitive material and image forming method | CANON KK (JP) | 1996-05-22 | — | — | EP | claimed |
| EP-0653680-A2 | Photosensitive composition, photosensitive material and image forming method | CANON KABUSHIKI KAISHA (JP) | 1995-05-17 | — | — | EP | claimed |
| US-9284323-B2 | Naphthalene acetic acid derivatives against HIV infection | GILEAD SCIENCES, INC. (US) | 2016-03-15 | — | — | US | disclosed |
| US-9284323-B2 | Naphthalene acetic acid derivatives against HIV infection | GILEAD SCIENCES, INC. (US) | 2016-03-15 | — | — | US | disclosed |
| US-20150111891-A1 | NAPHTHALENE ACETIC ACID DERIVATIVES AGAINST HIV INFECTION | GILEAD SCIENCES, INC. (US) | 2015-04-23 | — | — | US | disclosed |
| US-20150111891-A1 | NAPHTHALENE ACETIC ACID DERIVATIVES AGAINST HIV INFECTION | GILEAD SCIENCES, INC. (US) | 2015-04-23 | — | — | US | disclosed |
| US-20150111891-A1 | NAPHTHALENE ACETIC ACID DERIVATIVES AGAINST HIV INFECTION | GILEAD SCIENCES, INC. (US) | 2015-04-23 | — | — | US | disclosed |
| WO-2013103738-A1 | NAPTHALENE ACETIC ACID DERIVATIVES AGAINST HIV INFECTION | GILEAD SCIENCES, INC. (US) | 2013-07-11 | — | — | WO | disclosed |
| WO-2013103738-A1 | NAPTHALENE ACETIC ACID DERIVATIVES AGAINST HIV INFECTION | GILEAD SCIENCES, INC. (US) | 2013-07-11 | — | — | WO | disclosed |
| EP-1972351-B1 | Method for inactivation of microorganisms using photosensitizers | CARIDIANBCT BIOTECHNOLOGIES LLC (US) | 2011-05-11 | — | — | EP | disclosed |
| CN-101412775-B | Catalyst precursor for polymerization of propylene or combined polymerization, and preparation thereof | BEIJING JINDINGKE CHEMICAL TECHNOLOGY CO LTD | 2010-12-22 | — | — | CN | disclosed |
| EP-0332455-B1 | Photosensitive material and image forming method | CANON KK (JP) | 1996-06-05 | — | — | EP | disclosed |
| EP-0330504-B1 | Photosensitive material and image forming method | CANON KK (JP) | 1996-05-22 | — | — | EP | disclosed |
| EP-0360014-B1 | Photosensitive material and image forming method using same | CANON KK (JP) | 1996-01-03 | — | — | EP | disclosed |
| EP-0653680-A2 | Photosensitive composition, photosensitive material and image forming method | CANON KABUSHIKI KAISHA (JP) | 1995-05-17 | — | — | EP | disclosed |
| US-5415974-A | Silver halide, organic silver salt, polymerizable compound, heat-diffusing dye | CANON KABUSHIKI KAISHA (JP) | 1995-05-16 | — | — | US | disclosed |
| US-5260164-A | Silver halide, organic silver salt, cyclic reducing agent, the above compounds adapted to provide imagewise oxidized product of reducing agent upon imagewise exposure and heat development, polymer precursor, photopolymerization initiator | CANON KABUSHIKI KAISHA (JP) | 1993-11-09 | — | — | US | disclosed |
| US-5064744-A | Heat, photopolymerization, silver halide contrast | CANON KABUSHIKI KAISHA (JP) | 1991-11-12 | — | — | US | disclosed |
| US-5041369-A | Silver Halide, Silver Salt, Reducing Agent, Metal or Organic Dye | CANON KABUSHIKI KAISHA (JP) | 1991-08-20 | — | — | US | disclosed |
| EP-0332455-A2 | Photosensitive material and image forming method | CANON KABUSHIKI KAISHA (JP) | 1989-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150111891-A1 | NAPHTHALENE ACETIC ACID DERIVATIVES AGAINST HIV INFECTION | NFATC1, ACIN1, NAAA | HTT 1606/4885LMNA 2505/4885KDM4E 2881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.